© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement
Coordinating Cancer and HIV Research
illustration of multi-ethnic group of peple
Tips on How to Communicate U=U
Click Here for the Current Issue of POZ
An image from Houston’s “I am Life” HIV campaign

“I am Life” Campaign Reaffirms That People With HIV Matter

Meet the real people of color behind Houston’s effort to educate about PrEP and TasP.

Starting HIV Treatment Very Early Offers Strong Benefits

A new analysis of the global START trial found that health outcomes were better for those starting treatment within six months.

I’m considering buying prescription drugs from Canada. Is this legal? How do I know what I’m getting?

A look at what the law says about buying prescription drugs from Canada.

HIV May Persist in the Brain Despite Antiretroviral Treatment

After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.

Novel HIV Vaccine Approach Awarded $129M

Investigators led by Scripps Research will study vaccines that coax the immune system into creating antibodies that protect against HIV.

MUST read

2019 POZ 100
2019 POZ 100 Nomination Form
The POZ 100: Celebrating People 50 And Over
POZ Awards 2018: Winners as Voted by POZ Readers!
The Truth About the 7,000
Mark S. King: I Wrote “The Truth About the 7,000.” Now What?
Listen Now: Signorile and King Discuss “The Truth About the 7,000”
#African American
#Latino
#Women

New Algorithms Could Help Providers ID PrEP Candidates

Electronic prompts for clinicians to recommend Truvada to people at risk for HIV could help increase PrEP’s impact.

POZ Poll: Does your current HIV regimen include an NRTI?

HIV Meds Not Tied to Worse Neurodevelopment in HIV-Negative Infants

Researchers compared outcomes between babies born to HIV-positive mothers exposed to antiretrovirals and those who were not.

National Network for Latinx People Living With HIV Launches

LatinX+ will enable Latinx PLHIV to “define their own agenda.”
Mission Wellness pharmacy in San Francisco

Most At-Risk Gay Men Know About PrEP—but Only One Third Use It

PrEP use increased across regions and demographic groups but remains lower among Black and Latino men.

Hot topics

Forums: Support and discussion
Blogs: The community speaks
POZ Stories: Get inspired
Magazine: Search the archives
HIV: The Basics
Recursos de VIH/SIDA en Español
AIDS Is Everyday
Ask POZ

Center for AIDS Research in Alabama Receives $7.5M Grant Renewal

The money will help fund Birmingham’s efforts to achieve the UNAIDS 90-90-90 treatment goals.

Many Heavily Treated People With HIV Do Not Need NRTIs

Long-term salvage therapy without NRTIs suppressed HIV in nearly 80% of those who remained in care.
Descovy, which contains TAF, the updated version of tenofovir, along with emtricitabine.

Analysis Backs New Tenofovir’s Kidney Safety Over Old Version

Researchers compared data on more than 9,000 people with HIV who took either version of tenofovir.

Is It Safe to Interrupt HIV Treatment During Cure Studies?

Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?
Advertisement
Newsfeed
Treatment News
Features
Opinions